Good morning :)
Switch to
Place Order

Sun Pharma Advanced Research Co Ltd

SPARC
Health CarePharmaceuticals
SmallcapWith a market cap of ₹6,704 cr, stock is ranked 429
Moderate RiskStock is 2.96x as volatile as Nifty
254.505.65 (+2.27%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹6,704 cr, stock is ranked 429
Moderate RiskStock is 2.96x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-44.36
PB RatioPB Ratio
-39.85
Dividend YieldDiv. Yield
Sector PESector PE
38.07
Sector PBSector PB
5.10
Sector Div YldSctr Div Yld
0.67%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Sun Pharma Advanced Research Company Limited is engaged in the research and experimental development on natural sciences and engineering (Pharmacy).

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2018201920202021132.18196.3886.57258.37-196.99-145.42-312.41-151.14
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Press Release 
Announced OnDec 3, 2021

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated December 03, 2021, titled "SPARC enters into a licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target.". | Download

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated December 03, 2021, titled "SPARC enters into a licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target.". | Download

Loss of Share Certificates 
Announced OnDec 2, 2021

Sun Pharma Advanced Research Company Limited has informed the Exchange about Loss of Share Certificates | Download

Sun Pharma Advanced Research Company Limited has informed the Exchange about Loss of Share Certificates | Download

Loss of Share Certificates 
Announced OnDec 1, 2021

Sun Pharma Advanced Research Company Limited has informed the Exchange about Loss of Share Certificates | Download

Sun Pharma Advanced Research Company Limited has informed the Exchange about Loss of Share Certificates | Download

See all events